- Home
- PCSA vs FAMI Comparison
PCSA vs FAMI Comparison
Compare PCSA & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCSA
- FAMI
- Stock Information
- Founded
- PCSA 2011
- FAMI 2015
- Country
- PCSA United States
- FAMI China
- Employees
- PCSA N/A
- FAMI N/A
- Industry
- PCSA Biotechnology: Pharmaceutical Preparations
- FAMI Packaged Foods
- Sector
- PCSA Health Care
- FAMI Consumer Staples
- Exchange
- PCSA Nasdaq
- FAMI Nasdaq
- Market Cap
- PCSA 2.8M
- FAMI 3.1M
- IPO Year
- PCSA N/A
- FAMI 2018
- Fundamental
- Price
- PCSA $0.45
- FAMI $0.16
- Analyst Decision
- PCSA Strong Buy
- FAMI
- Analyst Count
- PCSA 1
- FAMI 0
- Target Price
- PCSA $6.00
- FAMI N/A
- AVG Volume (30 Days)
- PCSA 105.2K
- FAMI 4.4M
- Earning Date
- PCSA 03-28-2025
- FAMI 03-21-2025
- Dividend Yield
- PCSA N/A
- FAMI N/A
- EPS Growth
- PCSA N/A
- FAMI N/A
- EPS
- PCSA N/A
- FAMI N/A
- Revenue
- PCSA N/A
- FAMI $64,131,332.00
- Revenue This Year
- PCSA N/A
- FAMI N/A
- Revenue Next Year
- PCSA N/A
- FAMI N/A
- P/E Ratio
- PCSA N/A
- FAMI N/A
- Revenue Growth
- PCSA N/A
- FAMI N/A
- 52 Week Low
- PCSA $0.42
- FAMI $0.15
- 52 Week High
- PCSA $3.31
- FAMI $0.94
- Technical
- Relative Strength Index (RSI)
- PCSA 28.32
- FAMI 24.69
- Support Level
- PCSA $0.44
- FAMI $0.23
- Resistance Level
- PCSA $0.54
- FAMI $0.29
- Average True Range (ATR)
- PCSA 0.05
- FAMI 0.02
- MACD
- PCSA 0.00
- FAMI -0.01
- Stochastic Oscillator
- PCSA 16.03
- FAMI 9.79
About PCSA Processa Pharmaceuticals Inc.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
About FAMI Farmmi Inc.
Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.